Kindred Healthcare, Inc. (NYSE:KND) Shares Sold by Capstone Asset Management Co.
Capstone Asset Management Co. lowered its position in Kindred Healthcare, Inc. (NYSE:KND) by 5.8% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 29,526 shares of the health services provider’s stock after selling 1,820 shares during the period. Capstone Asset Management Co.’s holdings in Kindred Healthcare were worth $344,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of the company. Renaissance Technologies LLC boosted its stake in Kindred Healthcare by 33.7% in the fourth quarter. Renaissance Technologies LLC now owns 259,280 shares of the health services provider’s stock worth $2,035,000 after buying an additional 65,400 shares during the period. Norges Bank purchased a new stake in Kindred Healthcare during the fourth quarter worth approximately $8,342,000. Highbridge Capital Management LLC purchased a new stake in Kindred Healthcare during the fourth quarter worth approximately $300,000. Louisiana State Employees Retirement System boosted its stake in Kindred Healthcare by 1.5% in the first quarter. Louisiana State Employees Retirement System now owns 34,700 shares of the health services provider’s stock worth $290,000 after buying an additional 500 shares during the period. Finally, Nisa Investment Advisors LLC boosted its stake in Kindred Healthcare by 691.7% in the first quarter. Nisa Investment Advisors LLC now owns 66,900 shares of the health services provider’s stock worth $559,000 after buying an additional 58,450 shares during the period. Institutional investors and hedge funds own 88.88% of the company’s stock.
Kindred Healthcare, Inc. (NYSE:KND) traded down 1.37% during trading on Thursday, hitting $7.20. The company had a trading volume of 279,386 shares. The company’s 50 day moving average price is $10.44 and its 200-day moving average price is $9.21. Kindred Healthcare, Inc. has a 12 month low of $5.65 and a 12 month high of $11.90. The company’s market cap is $626.58 million.
Kindred Healthcare (NYSE:KND) last released its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.03. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the prior year, the business earned $0.38 earnings per share. Kindred Healthcare’s quarterly revenue was down 4.6% on a year-over-year basis. Equities analysts expect that Kindred Healthcare, Inc. will post $0.51 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: This article was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/08/10/kindred-healthcare-inc-nyseknd-shares-sold-by-capstone-asset-management-co.html.
A number of analysts have recently commented on KND shares. Zacks Investment Research upgraded Kindred Healthcare from a “hold” rating to a “buy” rating and set a $11.00 target price on the stock in a research report on Wednesday, May 3rd. UBS AG reissued a “neutral” rating and set a $10.50 price target (up previously from $8.00) on shares of Kindred Healthcare in a report on Friday, May 5th. Royal Bank Of Canada reissued a “hold” rating and set a $10.00 price target on shares of Kindred Healthcare in a report on Friday, May 5th. Barclays PLC reissued a “buy” rating and set a $13.00 price target (up previously from $11.00) on shares of Kindred Healthcare in a report on Sunday, May 7th. Finally, Mizuho reissued a “neutral” rating and set a $9.00 price target on shares of Kindred Healthcare in a report on Monday, July 3rd. Five research analysts have rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $9.94.
About Kindred Healthcare
Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.
Want to see what other hedge funds are holding KND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kindred Healthcare, Inc. (NYSE:KND).
Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.